PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31391337-4	2019	Here we demonstrate that the FDA-approved drug niclosamide, a potent inhibitor of TMEM16A identified by high-throughput screening, is an inhibitor of both TMEM16A and TMEM16F.	Niclosamide	47-58	anoctamin 6	Mus musculus	167-174	
31391337-7	2019	TMEM16A and TMEM16F support exocytic release of mucus and inflammatory mediators, both of which are blocked by niclosamide.	Niclosamide	111-122	anoctamin 6	Mus musculus	12-19